Urteste SA Sustainability Reports

Urteste S.A. develops innovative medical technology for early-stage cancer diagnostics. Its non-invasive diagnostic methodology focuses on detecting multiple types of tumors by measuring the activity of proteolytic enzymes within a single urine sample.

Sector: Professional & technical services

Country: Poland

Exchange: Warsaw Stock Exchange

LEI: 259400Q4S6JIKFQHGU06

FIGI: BBG0136J6WX1

No reports are currently available in our catalogue.